British Association of Dermatologists’ guidelines for the management of alopecia areata 2012
Conflicts of interest
None of the authors has a financial or commercial interest in any of the treatments discussed. A.G.M. occasionally acts as a consultant to pharmaceutical companies who manufacture and market products for the treatment of hair loss disorders.
This is an updated guideline prepared for the British Association of Dermatologists’ (BAD) Clinical Standards Unit, made up of the Therapy & Guidelines (T&G) subcommittee. Members of the Clinical Standards Unit are: J. Hughes (Chairman T&G), J. McLelland, S. Punjabi, D.A. Buckley, I. Nasr, V.J. Swale, C.E. Duarte Williamson, P.M. McHenry, S. Wagle (British National Formulary), S. Amin (British National Formulary), R. Davis (British Dermatological Nursing Group), S.E. Haveron (BAD Scientific Administrator), M.F. Mohd Mustapa (BAD Clinical Standards Manager).
Guidelines produced in 2003 by the British Association of Dermatologists; reviewed and updated 2012.